kidney cancernon–clear cell renal cell carcinomapapillaryrenal cell carcinomaNon-clear cell renal cell carcinoma (nccRCC) accounts for approximately 25% of RCC diagnoses. Although broadly labeled as "nccRCC," they comprised a host of histologies that include papillary, chromophobe, unclassi...
Treatment of kidney cancer TOP Treatment for localized tumors Treatment for advanced tumors Immune therapy - usually done with a drug called interleukin-2. Anti-angiogenic therapy - Made with medications that reduce the blood supply to the tumor, slowing their growth. The most commonly used drugs ...
Renal cell carcinoma (RCC) is an important clinical problem for which an effective treatment has yet to be developed. Importantly, the 5-year survival is b... R Erlandsson - 《Cancer Genetics & Cytogenetics》 被引量: 49发表: 1998年 Molecular study of a new family with hereditary renal cel...
This is something we’ve been debating for years in kidney cancer. It’s probably time to move beyond this argument, but it still comes up in practice: are you going to get patients with ipilimumab-nivolumab as their first treatment or 1 of the I/O–TKI regimens? I won’t read this ...
The tumor is very malignant with a higher relapse rate and wider distribution of metastases than Wilm's tumor. Case History: We report here two cases of clear cell sarcoma of kidney, both alive after 03 years of initial diagnosis and treatment.关键词:...
A variety of treatments are available, including radiotherapy, chemotherapy, immunotherapy and targeted therapy, but distant metastasis remains an important obstacle limiting the treatment effect in kidney renal clear cell carcinoma due to drug resistance and severe side effects [4,[6], [7], [8]]...
Adult clear cell sarcoma of the kidney: A case report Background Clear cell sarcoma of the kidney (CCSK) in adults is extremely rare. Optimal treatment of adult patients with CCSK remains unclear. Case presen... AR Kural,B Onal,H Ozkara,... - 《Bmc Urology》 被引量: 21发表: 2006年...
Clear cell sarcoma of the kidney: A review 2012, European Journal of Cancer Citation Excerpt : The mean age of patients with CCSK at presentation is about 36 months; Argani et al. found that 50% of their 351 cases were diagnosed between 2 and 3 years of age.3,10–12 CCSK is extremely...
treatment response [142]. Another study constructed a ubiquitin score to assess the ubiquitination outcome of individual patients, finding that the high-score group is associated with higher levels of immune cell infiltration and expression of PD1/PD-L1/CTLA-4, possibly indicating sensitivity to PD1...
Kidney Renal Clear Cell Carcinoma (KIRC) accounts for 75% of all renal cancers. Previous study had conflict evidences regarding NR1B2 role in cancer, and its expression and biological role in KIRC remained unclear. Our aims were to characterize the role